These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31144241)

  • 41. Antibiotic Prescribing Patterns for Hospitalized children with Community-Acquired Pneumonia in a Secondary Care Center.
    Albuhairi S; Farhan MA; Alanazi S; Althaqib A; Albeladi K; Alarfaj S; Alhezemy R; Ali MG; Faraz A; Alsudais M; Alolayan A
    J Infect Public Health; 2021 Aug; 14(8):1035-1041. PubMed ID: 34166877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients. A pharmaco-economic study based on a meta-analysis.
    Wessels F; Anderson AN; Ebrahim O
    S Afr Med J; 1998 Mar; 88(3):251-5. PubMed ID: 9608289
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prevalence of bacteremia in pediatric patients with community-acquired pneumonia: guidelines to reduce the frequency of obtaining blood cultures.
    Heine D; Cochran C; Moore M; Titus MO; Andrews AL
    Hosp Pediatr; 2013 Apr; 3(2):92-6. PubMed ID: 24340408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The development of pharmacokinetically enhanced amoxicillin/clavulanate for the management of respiratory tract infections in adults.
    File TM
    Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S131-4. PubMed ID: 18029151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coverage of atypical pathogens for hospitalised patients with community-acquired pneumonia is not guided by clinical parameters.
    Piso RJ; Arnold C; Bassetti S
    Swiss Med Wkly; 2013; 143():w13870. PubMed ID: 24089030
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cefuroxime compared to amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
    Lim TK
    Singapore Med J; 1997 Mar; 38(3):139. PubMed ID: 9269388
    [No Abstract]   [Full Text] [Related]  

  • 47. Antibiotic strategy in severe community-acquired pneumococcal pneumonia.
    Le Bris-Tomczak A; Bedos JP; Billon C; Samdjee F; Le Monnier A
    Med Mal Infect; 2012 May; 42(5):226-34. PubMed ID: 22583782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of Antibiotic Prescribing for Pediatric Community-Acquired Pneumonia in Children's and Non-Children's Hospitals.
    Tribble AC; Ross RK; Gerber JS
    JAMA Pediatr; 2019 Feb; 173(2):190-192. PubMed ID: 30534969
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prospective and comparative study between cefuroxime, ceftriaxone and amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia].
    Sánchez ME; Gómez J; Gómez Vargas J; Baños V; Ruiz Gómez J; Muñoz L; Simarro E; Soto MC; Canteras M; Valdés M
    Rev Esp Quimioter; 1998 Jun; 11(2):132-8. PubMed ID: 9795298
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quality of antibiotic prescribing for pediatric community-acquired Pneumonia in outpatient care.
    Saatchi A; Haverkate MR; Reid JN; Shariff SZ; Povitz M; Patrick DM; Silverman M; Morris AM; McCormack J; Marra F
    BMC Pediatr; 2023 Oct; 23(1):542. PubMed ID: 37898747
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibiotic treatment of children with community-acquired pneumonia: comparison of penicillin or ampicillin versus cefuroxime.
    Dinur-Schejter Y; Cohen-Cymberknoh M; Tenenbaum A; Brooks R; Averbuch D; Kharasch S; Kerem E
    Pediatr Pulmonol; 2013 Jan; 48(1):52-8. PubMed ID: 22431471
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative evaluation of a clinical intervention aimed at changing prescriber behaviour in response to new guidelines.
    Doyon S; Perreault M; Marquis C; Gauthier J; Lebel D; Bailey B; Collin J; Bussières JF
    J Eval Clin Pract; 2009 Dec; 15(6):1111-7. PubMed ID: 20367713
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evolution of amoxicillin/clavulanate in the treatment of adults with acute bacterial rhinosinusitis and community-acquired pneumonia in response to antimicrobial-resistance patterns.
    File TM; Benninger MS; Jacobs MR
    Clin Lab Med; 2004 Jun; 24(2):531-51. PubMed ID: 15177852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Guideline Adherence in Diagnostic Testing and Treatment of Community-Acquired Pneumonia in Children.
    McLaren SH; Mistry RD; Neuman MI; Florin TA; Dayan PS
    Pediatr Emerg Care; 2021 Oct; 37(10):485-493. PubMed ID: 30829848
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Guidelines to Manage Community-Acquired Pneumonia.
    Wunderink RG
    Clin Chest Med; 2018 Dec; 39(4):723-731. PubMed ID: 30390744
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains.
    File TM; Garau J; Jacobs MR; Wynne B; Twynholm M; Berkowitz E
    Int J Antimicrob Agents; 2005 Feb; 25(2):110-9. PubMed ID: 15664480
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibiotic Choice for Children Hospitalized With Pneumonia and Adherence to National Guidelines.
    Williams DJ; Edwards KM; Self WH; Zhu Y; Ampofo K; Pavia AT; Hersh AL; Arnold SR; McCullers JA; Hicks LA; Bramley AM; Jain S; Grijalva CG
    Pediatrics; 2015 Jul; 136(1):44-52. PubMed ID: 26101356
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule.
    Kanwar M; Brar N; Khatib R; Fakih MG
    Chest; 2007 Jun; 131(6):1865-9. PubMed ID: 17400668
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Current status of diagnosis and treatment of community-acquired pneumonia in Shanghai revealed by a questionnaire analysis].
    Liu J; Zhang J; Cheng QJ; Xu JF; Jie ZJ; Jiao Y; Huang Y; Qu JM
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Apr; 41(4):288-295. PubMed ID: 29690685
    [No Abstract]   [Full Text] [Related]  

  • 60. Assessment of the impact of clinical recommendations on antibiotic use for CAP and HCAP: results from an implementation program in an Academic Hospital.
    Cattani G; Madia A; Arnoldo L; Brunelli L; Celotto D; Grillone L; Valent F; Castriotta L; Pea F; Bassetti M; Brusaferro S
    Ann Ig; 2020; 32(4):344-356. PubMed ID: 32744293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.